Lynn Stagon

Lynn Stagon serves as Vice President of Worldwide Immunology Strategy & Commercial Development at Bristol Myers Squibb, where responsibilities include overseeing the global Immunology franchise and guiding the commercialization of pipeline assets. With a career at Bristol Myers Squibb since 1996, Lynn has held various leadership roles including Vice President of Worldwide Commercial, Immunology & Fibrosis, and Executive Director, leading the development of strategies for emerging therapeutic areas and successful product launches such as Eliquis. Lynn's extensive experience also includes managerial positions at Pharmedica Communications, ALK Laboratories, and Pfizer, alongside a solid academic foundation with an MBA in Marketing from The University of Chicago Booth School of Business and a B.A. in Biochemistry from Connecticut College.